In silico

For other uses, see In silico (disambiguation) .

A forest of synthetic pyramidal dendrites generated in silico using Cajal ’s laws of neuronal branching

In the realm of biology and other experimental sciences, the term in silico refers to experiments conducted on a computer or via computer simulation software. This pseudo-Latin phrase, meaning “in silicon,” alludes to the silicon used in computer chips. Coined in 1987, it draws inspiration from the well-established Latin phrases in vivo , in vitro , and in situ , which describe experiments performed in living organisms, outside living organisms, and in their natural environment, respectively. The adoption of in silico reflects the growing importance of computational methods in scientific research, particularly in systems biology , where complex biological systems are modeled and analyzed using advanced algorithms and high-performance computing.

History

The phrase in silico was first introduced by Christopher Langton in 1987 to describe the emerging field of artificial life . This term was used in the announcement of a workshop on artificial life held at the Los Alamos National Laboratory . The workshop aimed to explore the potential of computational models to simulate life-like processes, marking a significant milestone in the integration of computer science and biology.

In 1989, the term gained further traction when Pedro Miramontes , a mathematician from the National Autonomous University of Mexico (UNAM), used it to characterize biological experiments conducted entirely within a computer. Miramontes presented his work, titled “DNA and RNA Physicochemical Constraints, Cellular Automata and Molecular Evolution,” at the workshop “Cellular Automata: Theory and Applications” in Los Alamos, New Mexico . This work was later incorporated into Miramontes’ dissertation, solidifying the term’s place in scientific literature.

The use of in silico was further popularized through white papers written to support the creation of bacterial genome programs by the Commission of the European Community. The first referenced paper where in silico appears was written by a French team in 1991, highlighting the term’s growing acceptance in the scientific community. Additionally, the first referenced book chapter featuring in silico was authored by Hans B. Sieburg in 1990 and presented during a Summer School on Complex Systems at the Santa Fe Institute .

Originally, the phrase in silico was specifically applied to computer simulations that modeled natural or laboratory processes across various natural sciences. It did not encompass generic calculations performed by computers, emphasizing its specialized role in simulating complex biological and chemical systems.

Drug Discovery with Virtual Screening

Main article: Virtual screening

In the field of medicine, in silico studies are believed to hold immense potential for accelerating the rate of discovery while reducing the need for expensive laboratory work and clinical trials. One prominent application is in the realm of drug discovery, where computational methods can be employed to produce and screen drug candidates more efficiently. For instance, in 2010, researchers utilized the protein docking algorithm EADock (see Protein-ligand docking ) to identify potential inhibitors to an enzyme associated with cancer activity. Remarkably, 50% of the molecules identified in silico were later confirmed to be active inhibitors in vitro, demonstrating the effectiveness of computational approaches in drug discovery.

This method contrasts with the traditional use of expensive high-throughput screening (HTS) robotic labs, which physically test thousands of diverse compounds daily. HTS often yields a hit rate of around 1% or less, with even fewer compounds proving to be genuine leads following further testing (see drug discovery ). The computational approach offers a more cost-effective and efficient alternative, enabling researchers to focus on the most promising candidates.

An illustrative example of this technique’s application is its use in a drug repurposing study aimed at finding potential cures for COVID-19 (SARS-CoV-2). By leveraging computational screening, researchers were able to identify existing drugs that could be repurposed to combat the novel coronavirus, showcasing the versatility and power of in silico methods in addressing urgent medical challenges.

Cell Models

Efforts to establish computer models of cellular behavior have made significant strides in recent years. For example, in 2007, researchers developed an in silico model of tuberculosis to aid in drug discovery. One of the primary advantages of this model is its ability to simulate growth rates faster than real time, allowing phenomena of interest to be observed in minutes rather than months. This acceleration in simulation time enables researchers to rapidly test and evaluate potential drug candidates, significantly expediting the drug discovery process.

Further advancements have been made in modeling specific cellular processes, such as the growth cycle of Caulobacter crescentus . These detailed models provide valuable insights into the intricate mechanisms governing cellular behavior, offering a deeper understanding of biological systems.

Despite these achievements, current in silico cell models fall short of providing an exact, fully predictive representation of a cell’s entire behavior. Limitations in our understanding of molecular dynamics and cell biology , coupled with the absence of sufficient computer processing power, necessitate large simplifying assumptions. These assumptions, while enabling the creation of functional models, constrain the usefulness and accuracy of present in silico cell models. As computational power and biological knowledge continue to advance, it is anticipated that these models will become increasingly sophisticated and predictive.

Genetics

The advent of DNA sequencing has revolutionized the field of genetics, enabling the generation of vast amounts of digital genetic sequences . These sequences can be stored in sequence databases , where they are subjected to various forms of analysis (see Sequence analysis ). Additionally, digital sequences can be altered or used as templates for creating new actual DNA through artificial gene synthesis . This capability has opened up new avenues for genetic research, allowing scientists to manipulate and study genetic material in ways that were previously unimaginable.

The integration of computational methods in genetics has facilitated the exploration of complex genetic interactions and the identification of potential therapeutic targets. By leveraging in silico approaches, researchers can simulate genetic processes, predict the outcomes of genetic manipulations, and design novel genetic constructs with enhanced properties. This synergy between computation and genetics holds great promise for advancing our understanding of genetic mechanisms and developing innovative solutions to genetic disorders.

Other Examples

In silico computer-based modeling technologies have found applications in a wide range of scientific and medical fields. Some notable examples include:

Whole cell analysis of prokaryotic and eukaryotic hosts: This includes the study of organisms such as E. coli , B. subtilis , yeast , and various human cell lines. By creating detailed computational models of these organisms, researchers can gain insights into their cellular processes and identify potential targets for therapeutic intervention.
Discovery of potential cure for COVID-19: The computational screening of existing drugs has been employed to identify potential treatments for COVID-19. This approach leverages the vast amount of data available on drug interactions and biological pathways to rapidly identify promising candidates for further testing.
Bioprocess development and optimization: Computational models are used to optimize the yield of various bioprocesses, such as the production of biofuels, pharmaceuticals, and other valuable compounds. By simulating and analyzing these processes, researchers can identify the most efficient and cost-effective methods for large-scale production.
Simulation of oncological clinical trials: The use of grid computing infrastructures, such as the European Grid Infrastructure , has enabled the simulation of clinical trials for cancer treatments. These simulations aim to improve the performance and effectiveness of clinical trials, ultimately leading to better outcomes for cancer patients.
Analysis, interpretation, and visualization of heterologous data sets: Computational methods are employed to integrate and analyze data from various sources, such as genome , transcriptome , and proteome data. This holistic approach provides a comprehensive understanding of biological systems and facilitates the identification of key regulatory mechanisms.
Validation of taxonomic assignment steps in herbivore metagenomics study: In silico methods are used to validate the taxonomic assignments in metagenomic studies, ensuring the accuracy and reliability of the results. This is particularly important in the study of herbivore microbiomes, where the identification of microbial species can provide valuable insights into their ecological roles.
Protein design: Software packages such as RosettaDesign, which is free for academic use, enable the computational design of proteins with specific properties. This approach has been successfully applied to the design of novel proteins with enhanced stability and functionality, demonstrating the power of computational methods in protein engineering.

In Silico